Articles tagged with: Interview with Dr Julio Montaner

The science has changed. Know the facts, reduce stigma, stop criminalization of HIV

published: November, 30, 2014 Written by // Guest Authors - Revolving Door Categories // Sexual Health, Health, Legal, Treatment, Living with HIV, Opinion Pieces, Revolving Door, Guest Authors

Three new videos for World AIDS Day from the HIV Disclosure Project explore the connections between what we now know about risk of transmission and how that might impact HIV stigma, disclosure and criminalization

The science has changed. Know the facts, reduce stigma, stop criminalization of HIV

The HIV Disclosure Project addresses the complexities of disclosing one's HIV status to potential sex partners through workshops based on role play and theatre. The aim is to provide safe spaces for people to meet, identify barriers to disclosure, while keeping the .goal on the need to raise pubic awareness of the risks involved in disclosure - risks which are created by stigma and lack of basic information about HIV. The HIV Disclosure Project has been involved in workshops across Canada and

(Reprise) A Passionate Man: the Julio Montaner Interview, Part Two

published: November, 09, 2012 Written by // Bob Leahy - Publisher Categories // Features and Interviews, Sexual Health, Health, Living with HIV, Opinion Pieces, Bob Leahy - Publisher

Living in an undetectable age: the straight talk from BC’s Julio Montaner on when to use condoms, when to start treatment, the role of PreP and how we can beat the epidemic .

(Reprise) A Passionate Man: the Julio Montaner Interview, Part Two

This interview was originally published on PositiveLite.com. January 25, 2012. In part one of this in-depth interview with PositiveLite.com editor Bob Leahy, Dr. Julio Montaner, director of the B.C. Centre for Excellence in HIV/AIDS, discussed his disappointment with Canada’s uptake of treatment as prevention despite the strategy being lauded elsewhere, including in Time, Science, the USA and China. (Read part one here. In  part two, Bob explores some of the objections raised to treatment

(Reprise) Unacceptable. Reprehensible. Strong words on Canada’s approach to HIV prevention from one of its own.

published: November, 08, 2012 Written by // Bob Leahy - Publisher Categories // Activism, Research, Features and Interviews, Sexual Health, Health, Opinion Pieces, Bob Leahy - Publisher

Bob Leahy with Part One of his exclusive interview with British Columbia’s most famous scientist, Dr Julio Montaner. Treatment as prevention is Montaner’s passion and the world is listening – and acting. But not Canada, he says – and he’s angry!

(Reprise) Unacceptable. Reprehensible. Strong words on Canada’s approach to HIV prevention from one of its own.

This interview was originally published on PositiveLite.com January 18, 2012. Dr Julio Montaner, head of the British Columbia Centre for Excellence in HIV/AIDS  is proud of what he and his Province have achieved in reducing HIV transmission rates through treatment as prevention strategies. It’s a trend he doesn’t see elsewhere in Canada, not that he hasn’t tried to make it happen. “The public needs to get incensed” he said to me last week. “I‘ve been in the White House three t

When to start treatment?

published: April, 03, 2012 Written by // Bob Leahy - Publisher Categories // Current Affairs, Treatment Guidelines -including when to start, Health, Treatment, Living with HIV, Opinion Pieces, Bob Leahy - Publisher

New US guidelines released just last week recommend treatment for all people with HIV infection. Are they a step in the right direction, something that others should consider following? Bob Leahy reports.

When to start treatment?

Newly updated US treatment guidelines are recommending antiretroviral treatment for all people with HIV infection, rather than starting at a particular CD4 range. But for those about to start treatment and their doctors, it’s not quite that simple; the strength of the recommendations varies by category of patient. Here is how a simplified scale looks: CD4 count less than 350 – strong recommendation CD4 count 350 to 500 - strong recommendation CD4 count over 500 – moderate recommend